Inhibition of Neuroblastoma Tumor Growth by Targeted Delivery of MicroRNA-34a Using Anti-Disialoganglioside GD2 Coated Nanoparticles

Kinetics of immunoassays with particles as labels: effect of antibody coupling using dendrimers as linkers

(2011) Vladimir Gubala et al.   ANALYST

Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma

(2011) Danielle M. Patterson et al.   ANGIOGENESIS

MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma

(2011) Amanda Tivnan et al.   BMC CANCER

MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma

(2011) Isabella Bray et al.   CANCER LETTERS

MicroRNA therapeutics in preclinical cancer models

(2011) Minlee Kim et al.   LANCET ONCOLOGY

Neuroblastoma-targeted Nanoparticles Entrapping siRNA Specifically Knockdown ALK

(2011) Daniela Di Paolo et al.   MOLECULAR THERAPY

Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice

(2011) Phong Trang et al.   MOLECULAR THERAPY

The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers

(2011) Carlee E. Ashley et al.   NATURE MATERIALS

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

(2011) Can Liu et al.   NATURE MEDICINE

An integrin-binding N-terminal peptide region of TIMP-2 retains potent angio-inhibitory and anti-tumorigenic activity in vivo

(2011) Dong-Wan Seo et al.   PEPTIDES

MicroRNA-34a: A Novel Tumor Suppressor in p53-mutant Glioma Cell Line U251

(2010) Shihai Luan et al.   ARCHIVES OF MEDICAL RESEARCH

Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma

(2010) Huiqing Liu et al.   BMC Systems Biology

microRNA Signature and Expression of Dicer and Drosha Can Predict Prognosis and Delineate Risk Groups in Neuroblastoma

(2010) R.-J. Lin et al.   CANCER RESEARCH

MicroRNA Mediates DNA Demethylation Events Triggered by Retinoic Acid during Neuroblastoma Cell Differentiation

(2010) S. Das et al.   CANCER RESEARCH

Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34

(2010) J. F. Wiggins et al.   CANCER RESEARCH

MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells

(2010) Ronald T.K. Pang et al.   CARCINOGENESIS

Thelet-7microRNA reduces tumor growth in mouse models of lung cancer

(2010) Aurora Esquela-Kerscher et al.   CELL CYCLE

Chromosomal and MicroRNA Expression Patterns Reveal Biologically Distinct Subgroups of 11q- Neuroblastoma

(2010) P. G. Buckley et al.   CLINICAL CANCER RESEARCH

Anti-GD2 Antibody Therapy for GD2-Expressing Tumors

(2010) F. Navid et al.   CURRENT CANCER DRUG TARGETS

Therapeutic targeting of miRNAs in neuroblastoma

(2010) Raymond L Stallings et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Accurate prediction of neuroblastoma outcome based on miRNA expression profiles

(2010) Johannes H. Schulte et al.   INTERNATIONAL JOURNAL OF CANCER

Direct and Coordinate Regulation of ATP-binding Cassette Transporter Genes by Myc Factors Generates Specific Transcription Signatures That Significantly Affect the Chemoresistance Phenotype of Cancer Cells

(2010) Antonio Porro et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Targeting multiple angiogenic pathways for the treatment of neuroblastoma

(2010) Regan F. Williams et al.   JOURNAL OF PEDIATRIC SURGERY

MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2

(2010) Niamh H Foley et al.   Molecular Cancer

Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy

(2010) Yunching Chen et al.   MOLECULAR THERAPY

miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma

(2010) Shyamal D. Weeraratne et al.   NEURO-ONCOLOGY

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

(2010) Alice L. Yu et al.   NEW ENGLAND JOURNAL OF MEDICINE

A comparison of mono and multivalent linkers and their effect on the colloidal stability of nanoparticle and immunoassays performance

(2010) Vladimir Gubala et al.   TALANTA

The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance

(2009) Yogesh B. Patil et al.   BIOMATERIALS

Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model

(2009) Janaiah Kota et al.   CELL

MicroRNA Involvement in the Pathogenesis of Neuroblastoma: Potential for MicroRNA Mediated Therapeutics

(2009) R. Stallings   CURRENT PHARMACEUTICAL DESIGN

New therapeutic targets for the treatment of high-risk neuroblastoma

(2009) Lars M. Wagner et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Silica nanoparticles as a delivery system for nucleic acid-based reagents

(2009) Christopher Hom et al.   JOURNAL OF MATERIALS CHEMISTRY

Biodegradable luminescent porous silicon nanoparticles for in vivo applications

(2009) Ji-Ho Park et al.   NATURE MATERIALS

MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors

(2009) P Mestdagh et al.   ONCOGENE

Widespread Dysregulation of MiRNAs by MYCN Amplification and Chromosomal Imbalances in Neuroblastoma: Association of miRNA Expression with Survival

(2009) Isabella Bray et al.   PLoS One

Global MYCN Transcription Factor Binding Analysis in Neuroblastoma Reveals Association with Distinct E-Box Motifs and Regions of DNA Hypermethylation

(2009) Derek M. Murphy et al.   PLoS One

Experimental and theoretical studies of the optimisation of fluorescence from near-infrared dye-doped silica nanoparticles

(2008) Robert I. Nooney et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest

(2008) Fang Sun et al.   FEBS LETTERS

Biodegradability of sol–gel silica microparticles for drug delivery

(2008) Kim S. Finnie et al.   JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY

A Functional Screen Identifies miR-34a as a Candidate Neuroblastoma Tumor Suppressor Gene

(2008) K. A. Cole et al.   MOLECULAR CANCER RESEARCH

The MYCN oncogene is a direct target of miR-34a

(2008) J S Wei et al.   ONCOGENE

N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastoma

(2008) J Kang et al.   ONCOGENE

Antagomir-17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM

(2008) Laura Fontana et al.   PLoS One

miR-34a repression of SIRT1 regulates apoptosis

(2008) M. Yamakuchi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MYCN regulates oncogenic MicroRNAs in neuroblastoma

(2007) Johannes H. Schulte et al.   INTERNATIONAL JOURNAL OF CANCER